ANAL CANCER STAGE 0

This adverse event was reported 31 times

ANAL CANCER STAGE 0 is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RALTEGRAVIR 3 0.0006
1 DARUNAVIR 600 MG 3 0.0005
2 NELFINAVIR MESYLATE 1 0.0005
3 DARUNAVIR 7 0.0005
4 MARAVIROC 1 0.0004
5 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
6 INFLIXIMAB-DYYB 1 0.0003
7 LAMIVUDINE 5 0.0002
8 RITONAVIR 100 MG 2 0.0001
9 DOLUTEGRAVIR SODIUM 1 0.0001
See all drugs enriched for association with ANAL CANCER STAGE 0